Vivesto AB

Stocks

Market Closed - Nasdaq Stockholm 19:00:00 12/08/2026 +03			5-day change	1st Jan Change
8.670 ^SEK	-1.25%		-3.24%	-35.78%

07-07	Vivesto chairman Peter Zonabend increases his shareholding	FW
07-01	Vivesto Completes Enrollment in Cat Study of Paccal Vet	FW

Published on 11/24/2025 at 07:35 pm +03 - Modified on 11/25/2025 at 01:40 am +03

S&P Capital IQ

Presenter Speech
Mikael Magnusson (Attendees)

The clock strikes 3:00 p.m., and we welcome viewers here to Vivesto's business update. Today, we will hear about the company with a focus towards the

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Full unlimited browsing across the entire site

Access to all the news and all the data

Access to US, EUROPE AND ASIA Portfolios

Zero Ads for a completely uninterrupted reading experience

Pro Tools: Expert insights, Expert Screeners, historical financial data and reports, thematic lists, transcripts...

07-07	Vivesto chairman Peter Zonabend increases his shareholding	FW
07-01	Vivesto Completes Enrollment in Cat Study of Paccal Vet	FW
07-01	Vivesto Completes Recruitment in Paccal Vet Dose-Finding Study in Cats and Determines Maximum Tolerated Dose	CI
06-26	Vivesto Completes Enrollment in Canine Study	FW
06-26	Vivesto Completes Recruitment in Paccal Vet Dog Pilot Study	CI
06-16	Vivesto AB Reports Positive Results From Intravenous Cantrixil Pharmacokinetic And Toxicology Study	CI
06-16	Vivesto reports positive results for intravenous Cantrixil	FW
06-05	Sweden's Vivesto Names New Finance Chief	MT
06-05	Vivesto appoints Björn Svanström as new CFO	FW
06-05	Vivesto AB Announces Chief Financial Officer Changes	CI
05-26	DNB Carnegie adjusts Vivesto fair value following reverse stock split	FW
05-20	Vivesto trades on Nasdaq Stockholm today following 1:100 reverse stock split	FW
05-20	Calendar Wednesday May 20	FW
05-13	Vivesto sets record date for reverse share split as May 21, 2026	RE
05-13	Vivesto sets timetable for reverse stock split	FW